Navigation Links
The Revelation of Man: A New Novel That Explains The Enduring Survival and Existence of Homosexuals If They Don't Naturally Reproduce
Date:6/14/2011

WASHINGTON, June 14, 2011 /PRNewswire/ -- A fundamental question regarding man's existence has been left unanswered by science and religion for over two thousand years. As homosexuals don't naturally reproduce, their gene pool is not further advanced.  So, how do we explain their enduring survival and existence?  What if their existence served a necessary or divine purpose?  

If we're to believe Darwin's laws of evolution, the mere presence of homosexuals is an impossible outcome. On the other hand, organized religion provides no explanation only to declare homosexuality an abomination.  But what if the earth's population began to decline at an increasing rate?  What if straight men suddenly but steadily began declaring themselves gay?  What if a young government researcher discovered genetic evidence to support this phenomenon?  What if an evangelical preacher stumbled upon this same evidence and used it to proclaim Revelation?

The answers to the above questions can be found in The Revelation of Man.  This riveting novel describes the journey of two desperate men as they seek to unravel the interconnectivity of sexual orientation, genetics and Revelation.  Though they live and work worlds apart, their converging lives allow them to reveal answers that lay beyond anyone's imagination.

The Revelation of Man can be purchased from most E-Book sellers including Apple, Amazon, Barnes & Noble and Smashwords.  


'/>"/>
SOURCE David Schweon
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
2. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
3. Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study with Cimzia® (certolizumab pegol)
4. InVivo Therapeutics and The Miami Project to Cure Paralysis Form Strategic Research Collaboration to Develop Novel Treatments for Spinal Cord Injuries
5. Frost & Sullivan Award Acknowledges Noveldas Cutting-Edge Product Innovation
6. ImaginAb, Inc. Concludes Licensing Agreement With UCLA for Novel Radiochemistry Technology
7. NRL scientists demonstrate novel ionic liquid batteries
8. Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics
9. S*BIO Initiates Phase 2 Clinical Trial of its Novel JAK2 Inhibitor SB1518 in North America for Advanced Lymphoid Malignancies
10. Tolerx Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses
11. Novel nanowires boost fuel cell efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation President ... and Astronomy, has been selected for membership in ARCS Alumni Hall of Fame ... Prize in Fundamental physics for the discovery of the accelerating expansion of the universe, ...
(Date:10/7/2017)... 2017  The 2017 Nobel Prize in Chemistry ... Dubochet, Joachim Frank and Richard ... microscopy (cryo-EM) have helped to broaden the ... community. The winners worked with systems manufactured by ... highly resolved, three-dimensional images of protein structures that ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):